Indium(III) catalyzes the construction of cross-linked cyclic peptides, suggesting a novel synthetic approach in drug discovery.
Cyclic peptides represent a privileged class of scaffolds in drug discovery owing to their unique balance between structural rigidity and functional diversity. Herein, we disclose an indium(III)-catalyzed intramolecular dithiane-alkyne metathesis (DAM) that facilitates the efficient construction of Trp(C2)-alkene-cross-linked cyclic peptides with exclusive E-selectivity. This protocol directly transforms linear peptide precursors into diverse macrocycles with broad substrate scope, high atom economy, and operational simplicity. These features establish DAM as a mechanistically distinct and practical peptide stapling strategy.
No takes yet. Share an insight, caveat, or question.
Li et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: